Does OCREVUS stop new lesions?: An In-Depth Look at its Efficacy in MS
•
4 min read
Clinical trials have shown that for many patients with multiple sclerosis (MS), OCREVUS can dramatically reduce new brain lesions, a critical marker of disease activity. The question, **Does OCREVUS stop new lesions?**, is met with strong evidence suggesting it provides powerful suppression of new lesion formation in both relapsing and progressive forms of MS, though its efficacy is not absolute.
